Click here to get full coverage on Multiple affiliate sales and option exercises at Mineralys Therapeutics (MLYS) - Stock Titan

Multiple affiliate sales and option exercises at Mineralys Therapeutics (MLYS)  Stock Titan

Multiple affiliate sales and option exercises at Mineralys Therapeutics (MLYS) - Stock Titan

Click here to get full coverage on How FDA NDA Acceptance for Lorundrostat At Mineralys Therapeutics (MLYS) Has Changed Its Investment Story - Yahoo Finance

How FDA NDA Acceptance for Lorundrostat At Mineralys Therapeutics (MLYS) Has Changed Its Investment Story  Yahoo Finance

How FDA NDA Acceptance for Lorundrostat At Mineralys Therapeutics (MLYS) Has Changed Its Investment Story - Yahoo Finance

Click here to get full coverage on Trading the Move, Not the Narrative: (MLYS) Edition - Stock Traders Daily

Trading the Move, Not the Narrative: (MLYS) Edition  Stock Traders Daily

Trading the Move, Not the Narrative: (MLYS) Edition - Stock Traders Daily

Click here to get full coverage on MLYS: Lorundrostat advances toward FDA approval with strong clinical data and launch readiness - TradingView

MLYS: Lorundrostat advances toward FDA approval with strong clinical data and launch readiness  TradingView

MLYS: Lorundrostat advances toward FDA approval with strong clinical data and launch readiness - TradingView

Click here to get full coverage on Mineralys Therapeutics (Nasdaq: MLYS) Grants Equity Awards to New Hires - MyChesCo

Mineralys Therapeutics (Nasdaq: MLYS) Grants Equity Awards to New Hires  MyChesCo

Mineralys Therapeutics (Nasdaq: MLYS) Grants Equity Awards to New Hires - MyChesCo

Click here to get full coverage on Is Mineralys Therapeutics (MLYS) Still Attractive After An 88% One-Year Share Price Surge - simplywall.st

Is Mineralys Therapeutics (MLYS) Still Attractive After An 88% One-Year Share Price Surge  simplywall.st

Is Mineralys Therapeutics (MLYS) Still Attractive After An 88% One-Year Share Price Surge - simplywall.st

Click here to get full coverage on Mineralys (NASDAQ: MLYS) CMO exercises options, sells 22,575 shares in 10b5-1 plan - Stock Titan

Mineralys (NASDAQ: MLYS) CMO exercises options, sells 22,575 shares in 10b5-1 plan  Stock Titan

Mineralys (NASDAQ: MLYS) CMO exercises options, sells 22,575 shares in 10b5-1 plan - Stock Titan

Click here to get full coverage on Mineralys Therapeutics (MLYS) Appoints Jeffrey A. Munsie as Chief Legal Officer - Yahoo Finance

Mineralys Therapeutics (MLYS) Appoints Jeffrey A. Munsie as Chief Legal Officer  Yahoo Finance

Mineralys Therapeutics (MLYS) Appoints Jeffrey A. Munsie as Chief Legal Officer - Yahoo Finance

Click here to get full coverage on MLYS: NDA accepted for lorundrostat; launch prep and strong cash position support U.S. commercialization - TradingView

MLYS: NDA accepted for lorundrostat; launch prep and strong cash position support U.S. commercialization  TradingView

MLYS: NDA accepted for lorundrostat; launch prep and strong cash position support U.S. commercialization - TradingView

Click here to get full coverage on Does Mineralys Therapeutics (MLYS) NDA Momentum and Conference Push Reveal Its Core Hypertension Strategy? - simplywall.st

Does Mineralys Therapeutics (MLYS) NDA Momentum and Conference Push Reveal Its Core Hypertension Strategy?  simplywall.st

Does Mineralys Therapeutics (MLYS) NDA Momentum and Conference Push Reveal Its Core Hypertension Strategy? - simplywall.st

Click here to get full coverage on Mineralys Therapeutics (NASDAQ: MLYS) insider sale notice — 6,348 shares - Stock Titan

Mineralys Therapeutics (NASDAQ: MLYS) insider sale notice — 6,348 shares  Stock Titan

Mineralys Therapeutics (NASDAQ: MLYS) insider sale notice — 6,348 shares - Stock Titan

Click here to get full coverage on Mineralys Therapeutics (MLYS) Garnering Attention With Lorundrostat Progress - Yahoo Finance

Mineralys Therapeutics (MLYS) Garnering Attention With Lorundrostat Progress  Yahoo Finance

Mineralys Therapeutics (MLYS) Garnering Attention With Lorundrostat Progress - Yahoo Finance

Click here to get full coverage on [144] Mineralys Therapeutics, Inc. SEC Filing - Stock Titan

[144] Mineralys Therapeutics, Inc. SEC Filing  Stock Titan

[144] Mineralys Therapeutics, Inc. SEC Filing - Stock Titan

Click here to get full coverage on Is Mineralys Therapeutics, Inc. (MLYS) A Good Stock To Buy Now? - Yahoo Finance

Is Mineralys Therapeutics, Inc. (MLYS) A Good Stock To Buy Now?  Yahoo Finance

Is Mineralys Therapeutics, Inc. (MLYS) A Good Stock To Buy Now? - Yahoo Finance

Click here to get full coverage on MLYS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

MLYS Financials: Income Statement, Balance Sheet & Cash Flow  Stock Titan

MLYS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Click here to get full coverage on Is Mineralys Therapeutics (MLYS) Pricing Reflect The Recent Share Price Pullback - Yahoo Finance

Is Mineralys Therapeutics (MLYS) Pricing Reflect The Recent Share Price Pullback  Yahoo Finance

Is Mineralys Therapeutics (MLYS) Pricing Reflect The Recent Share Price Pullback - Yahoo Finance

Click here to get full coverage on Mineralys fireside chat at Bank of America conference streams May 12 - Stock Titan

Mineralys fireside chat at Bank of America conference streams May 12  Stock Titan

Mineralys fireside chat at Bank of America conference streams May 12 - Stock Titan

Click here to get full coverage on Does Mineralys Therapeutics’ (MLYS) FDA Progress and Legal Hire Reshape Its Cardiorenal Commercialization Strategy? - Yahoo Finance

Does Mineralys Therapeutics’ (MLYS) FDA Progress and Legal Hire Reshape Its Cardiorenal Commercialization Strategy?  Yahoo Finance

Does Mineralys Therapeutics’ (MLYS) FDA Progress and Legal Hire Reshape Its Cardiorenal Commercialization Strategy? - Yahoo Finance

Click here to get full coverage on Two new Mineralys hires get stock options and RSUs under Nasdaq rule - Stock Titan

Two new Mineralys hires get stock options and RSUs under Nasdaq rule  Stock Titan

Two new Mineralys hires get stock options and RSUs under Nasdaq rule - Stock Titan

Click here to get full coverage on FDA accepts Mineralys hypertension drug filing; Dec. 22 decision date - Stock Titan

FDA accepts Mineralys hypertension drug filing; Dec. 22 decision date  Stock Titan

FDA accepts Mineralys hypertension drug filing; Dec. 22 decision date - Stock Titan

Click here to get full coverage on Is It Time To Reassess Mineralys Therapeutics (MLYS) After The Recent Share Price Pullback? - Yahoo Finance

Is It Time To Reassess Mineralys Therapeutics (MLYS) After The Recent Share Price Pullback?  Yahoo Finance

Is It Time To Reassess Mineralys Therapeutics (MLYS) After The Recent Share Price Pullback? - Yahoo Finance

Click here to get full coverage on Mineralys schedules first-quarter 2026 results call for May 6 - Stock Titan

Mineralys schedules first-quarter 2026 results call for May 6  Stock Titan

Mineralys schedules first-quarter 2026 results call for May 6 - Stock Titan

Click here to get full coverage on Mineralys (NASDAQ: MLYS) posts Q1 loss, holds $646M cash - Stock Titan

Mineralys (NASDAQ: MLYS) posts Q1 loss, holds $646M cash  Stock Titan

Mineralys (NASDAQ: MLYS) posts Q1 loss, holds $646M cash - Stock Titan

Click here to get full coverage on $MLYS stock is up 13% today. Here's what we see in our data. - Quiver Quantitative

$MLYS stock is up 13% today. Here's what we see in our data.  Quiver Quantitative

$MLYS stock is up 13% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on FDA accepts Mineralys (Nasdaq: MLYS) NDA for lorundrostat, sets Dec 2026 PDUFA - Stock Titan

FDA accepts Mineralys (Nasdaq: MLYS) NDA for lorundrostat, sets Dec 2026 PDUFA  Stock Titan

FDA accepts Mineralys (Nasdaq: MLYS) NDA for lorundrostat, sets Dec 2026 PDUFA - Stock Titan

Click here to get full coverage on Mineralys Therapeutics Insider Sold Shares Worth $652,638, According to a Recent SEC Filing - Moomoo

Mineralys Therapeutics Insider Sold Shares Worth $652,638, According to a Recent SEC Filing  Moomoo

Mineralys Therapeutics Insider Sold Shares Worth $652,638, According to a Recent SEC Filing - Moomoo

Click here to get full coverage on Mineralys Therapeutics (MLYS) Makes Progress With FDA For Hypertension - Yahoo Finance

Mineralys Therapeutics (MLYS) Makes Progress With FDA For Hypertension  Yahoo Finance

Mineralys Therapeutics (MLYS) Makes Progress With FDA For Hypertension - Yahoo Finance

Click here to get full coverage on Mineralys (MLYS) CMO logs small 10b5-1 share sale and option exercise - Stock Titan

Mineralys (MLYS) CMO logs small 10b5-1 share sale and option exercise  Stock Titan

Mineralys (MLYS) CMO logs small 10b5-1 share sale and option exercise - Stock Titan

Click here to get full coverage on A Look At Mineralys Therapeutics (MLYS) Valuation After FDA Accepts Lorundrostat NDA For Hypertension - simplywall.st

A Look At Mineralys Therapeutics (MLYS) Valuation After FDA Accepts Lorundrostat NDA For Hypertension  simplywall.st

A Look At Mineralys Therapeutics (MLYS) Valuation After FDA Accepts Lorundrostat NDA For Hypertension - simplywall.st

Click here to get full coverage on Insider Sale: Chief Medical Officer of $MLYS Sells 70,037 Shares | MLYS Stock News - Quiver Quantitative

Insider Sale: Chief Medical Officer of $MLYS Sells 70,037 Shares | MLYS Stock News  Quiver Quantitative

Insider Sale: Chief Medical Officer of $MLYS Sells 70,037 Shares | MLYS Stock News - Quiver Quantitative

Click here to get full coverage on Why Mineralys Therapeutics (MLYS) Is Up After Positive Lorundrostat Phase 3 Data and FDA Filing Plans - Yahoo Finance

Why Mineralys Therapeutics (MLYS) Is Up After Positive Lorundrostat Phase 3 Data and FDA Filing Plans  Yahoo Finance

Why Mineralys Therapeutics (MLYS) Is Up After Positive Lorundrostat Phase 3 Data and FDA Filing Plans - Yahoo Finance

Click here to get full coverage on Mineralys CMO Rodman sells $652,637 in company stock - Investing.com

Mineralys CMO Rodman sells $652,637 in company stock  Investing.com

Mineralys CMO Rodman sells $652,637 in company stock - Investing.com

Click here to get full coverage on Mineralys (MLYS) Q1 2026 Earnings Transcript - AOL.com

Mineralys (MLYS) Q1 2026 Earnings Transcript  AOL.com

Mineralys (MLYS) Q1 2026 Earnings Transcript - AOL.com

Click here to get full coverage on MLYS Stock Price and Chart — NASDAQ:MLYS - TradingView

MLYS Stock Price and Chart — NASDAQ:MLYS  TradingView

MLYS Stock Price and Chart — NASDAQ:MLYS - TradingView

Click here to get full coverage on (MLYS) Volatility Zones as Tactical Triggers - Stock Traders Daily

(MLYS) Volatility Zones as Tactical Triggers  Stock Traders Daily

(MLYS) Volatility Zones as Tactical Triggers - Stock Traders Daily

Click here to get full coverage on Biotech Mineralys offers 4-year stock awards to new hires - Stock Titan

Biotech Mineralys offers 4-year stock awards to new hires  Stock Titan

Biotech Mineralys offers 4-year stock awards to new hires - Stock Titan

Click here to get full coverage on Congleton, Mineralys Therapeutics CEO, sells $421k in MLYS stock - Investing.com

Congleton, Mineralys Therapeutics CEO, sells $421k in MLYS stock  Investing.com

Congleton, Mineralys Therapeutics CEO, sells $421k in MLYS stock - Investing.com

Click here to get full coverage on New blood pressure drug shows promise for hard-to-treat patients - Stock Titan

New blood pressure drug shows promise for hard-to-treat patients  Stock Titan

New blood pressure drug shows promise for hard-to-treat patients - Stock Titan

Click here to get full coverage on Mineralys (MLYS) Down (-4.6%): Phase 2 Sleep Apnea Trial Fails Primary Endpoint - Trefis

Mineralys (MLYS) Down (-4.6%): Phase 2 Sleep Apnea Trial Fails Primary Endpoint  Trefis

Mineralys (MLYS) Down (-4.6%): Phase 2 Sleep Apnea Trial Fails Primary Endpoint - Trefis

Click here to get full coverage on Mineralys Therapeutics (MLYS) CMO Rodman sold $548k in shares - Investing.com

Mineralys Therapeutics (MLYS) CMO Rodman sold $548k in shares  Investing.com

Mineralys Therapeutics (MLYS) CMO Rodman sold $548k in shares - Investing.com

Click here to get full coverage on We're Interested To See How Mineralys Therapeutics (NASDAQ:MLYS) Uses Its Cash Hoard To Grow - Moomoo

We're Interested To See How Mineralys Therapeutics (NASDAQ:MLYS) Uses Its Cash Hoard To Grow  Moomoo

We're Interested To See How Mineralys Therapeutics (NASDAQ:MLYS) Uses Its Cash Hoard To Grow - Moomoo

Click here to get full coverage on TD Cowen initiates coverage of Mineralys Therapeutics (MLYS) with buy recommendation - MSN

TD Cowen initiates coverage of Mineralys Therapeutics (MLYS) with buy recommendation  MSN

TD Cowen initiates coverage of Mineralys Therapeutics (MLYS) with buy recommendation - MSN

Click here to get full coverage on Mineralys (MLYS) Steals Spotlight From AstraZeneca, Reaches Fresh Peak - Yahoo Finance

Mineralys (MLYS) Steals Spotlight From AstraZeneca, Reaches Fresh Peak  Yahoo Finance

Mineralys (MLYS) Steals Spotlight From AstraZeneca, Reaches Fresh Peak - Yahoo Finance

Click here to get full coverage on Mineralys spikes as blood pressure drug undergoes FDA review - Seeking Alpha

Mineralys spikes as blood pressure drug undergoes FDA review  Seeking Alpha

Mineralys spikes as blood pressure drug undergoes FDA review - Seeking Alpha

Click here to get full coverage on Earnings Flash (MLYS) Mineralys Therapeutics Posts Q1 EPS -$0.47, vs. FactSet Est of -$0.47 - marketscreener.com

Earnings Flash (MLYS) Mineralys Therapeutics Posts Q1 EPS -$0.47, vs. FactSet Est of -$0.47  marketscreener.com

Earnings Flash (MLYS) Mineralys Therapeutics Posts Q1 EPS -$0.47, vs. FactSet Est of -$0.47 - marketscreener.com

Click here to get full coverage on Mineralys: 'Hold' As Hypertension OSA Data Barely Delivers And AstraZeneca On The Move - Seeking Alpha

Mineralys: 'Hold' As Hypertension OSA Data Barely Delivers And AstraZeneca On The Move  Seeking Alpha

Mineralys: 'Hold' As Hypertension OSA Data Barely Delivers And AstraZeneca On The Move - Seeking Alpha

Click here to get full coverage on Price-Driven Insight from (MLYS) for Rule-Based Strategy - Stock Traders Daily

Price-Driven Insight from (MLYS) for Rule-Based Strategy  Stock Traders Daily

Price-Driven Insight from (MLYS) for Rule-Based Strategy - Stock Traders Daily

Click here to get full coverage on Blood pressure drug wins FDA review as apnea study shows no gain - Stock Titan

Blood pressure drug wins FDA review as apnea study shows no gain  Stock Titan

Blood pressure drug wins FDA review as apnea study shows no gain - Stock Titan

Click here to get full coverage on Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2026 Earnings Call Transcript - Insider Monkey

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2026 Earnings Call Transcript  Insider Monkey

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2026 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Mineralys Therapeutics CEO Congleton sells $529k in MLYS stock - Investing.com

Mineralys Therapeutics CEO Congleton sells $529k in MLYS stock  Investing.com

Mineralys Therapeutics CEO Congleton sells $529k in MLYS stock - Investing.com

Click here to get full coverage on Mineralys: Pre-NDA Feedback Sets Stage For A Pivotal 2026 (NASDAQ:MLYS) - Seeking Alpha

Mineralys: Pre-NDA Feedback Sets Stage For A Pivotal 2026 (NASDAQ:MLYS)  Seeking Alpha

Mineralys: Pre-NDA Feedback Sets Stage For A Pivotal 2026 (NASDAQ:MLYS) - Seeking Alpha

Click here to get full coverage on TD Cowen Initiates Mineralys Therapeutics(MLYS.US) With Buy Rating - Moomoo

TD Cowen Initiates Mineralys Therapeutics(MLYS.US) With Buy Rating  Moomoo

TD Cowen Initiates Mineralys Therapeutics(MLYS.US) With Buy Rating - Moomoo

Click here to get full coverage on 416-share cashless exercise reported by Mineralys (NASDAQ: MLYS) - Stock Titan

416-share cashless exercise reported by Mineralys (NASDAQ: MLYS)  Stock Titan

416-share cashless exercise reported by Mineralys (NASDAQ: MLYS) - Stock Titan

Click here to get full coverage on Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update - Yahoo Finance

Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update  Yahoo Finance

Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update - Yahoo Finance

Click here to get full coverage on Mineralys: Big Pharma Threatens To Undermine Likely Hypertension Drug Approval (MLYS) - Seeking Alpha

Mineralys: Big Pharma Threatens To Undermine Likely Hypertension Drug Approval (MLYS)  Seeking Alpha

Mineralys: Big Pharma Threatens To Undermine Likely Hypertension Drug Approval (MLYS) - Seeking Alpha

Click here to get full coverage on Why Mineralys Therapeutics (MLYS) Is Up 5.1% After Completing Enrollment in EXPLORE-OSA Hypertension Trial - Yahoo Finance

Why Mineralys Therapeutics (MLYS) Is Up 5.1% After Completing Enrollment in EXPLORE-OSA Hypertension Trial  Yahoo Finance

Why Mineralys Therapeutics (MLYS) Is Up 5.1% After Completing Enrollment in EXPLORE-OSA Hypertension Trial - Yahoo Finance

Click here to get full coverage on MLYS Stock Climbs As FDA Review And New CLO Draw Trader Focus - timothysykes.com

MLYS Stock Climbs As FDA Review And New CLO Draw Trader Focus  timothysykes.com

MLYS Stock Climbs As FDA Review And New CLO Draw Trader Focus - timothysykes.com

Click here to get full coverage on Mineralys (MLYS) CEO sells 15,730 shares in Rule 10b5-1 stock plan trade - Stock Titan

Mineralys (MLYS) CEO sells 15,730 shares in Rule 10b5-1 stock plan trade  Stock Titan

Mineralys (MLYS) CEO sells 15,730 shares in Rule 10b5-1 stock plan trade - Stock Titan

Click here to get full coverage on Mineralys CMO Rodman sells $652,637 in company stock By Investing.com - Investing.com Nigeria

Mineralys CMO Rodman sells $652,637 in company stock By Investing.com  Investing.com Nigeria

Mineralys CMO Rodman sells $652,637 in company stock By Investing.com - Investing.com Nigeria

Click here to get full coverage on Mineralys therapeutics MLYS: Chief medical officer sells $59k in shares - Investing.com

Mineralys therapeutics MLYS: Chief medical officer sells $59k in shares  Investing.com

Mineralys therapeutics MLYS: Chief medical officer sells $59k in shares - Investing.com

Click here to get full coverage on Mineralys brings in veteran biotech lawyer as it advances lorundrostat - Stock Titan

Mineralys brings in veteran biotech lawyer as it advances lorundrostat  Stock Titan

Mineralys brings in veteran biotech lawyer as it advances lorundrostat - Stock Titan

Click here to get full coverage on Mineralys (MLYS) CMO exercises options and sells 2,170 shares under 10b5-1 plan - Stock Titan

Mineralys (MLYS) CMO exercises options and sells 2,170 shares under 10b5-1 plan  Stock Titan

Mineralys (MLYS) CMO exercises options and sells 2,170 shares under 10b5-1 plan - Stock Titan

Click here to get full coverage on Did New Phase 3 Results and FDA Milestones Just Shift Mineralys Therapeutics' (MLYS) Investment Narrative? - Yahoo Finance

Did New Phase 3 Results and FDA Milestones Just Shift Mineralys Therapeutics' (MLYS) Investment Narrative?  Yahoo Finance

Did New Phase 3 Results and FDA Milestones Just Shift Mineralys Therapeutics' (MLYS) Investment Narrative? - Yahoo Finance

Click here to get full coverage on David Rodman sells shares; Mineralys Therapeutics (NASDAQ: MLYS) Form 144 listing - Stock Titan

David Rodman sells shares; Mineralys Therapeutics (NASDAQ: MLYS) Form 144 listing  Stock Titan

David Rodman sells shares; Mineralys Therapeutics (NASDAQ: MLYS) Form 144 listing - Stock Titan

Click here to get full coverage on Mineralys Stock Rises as FDA Accepts NDA for Hypertension Drug - Yahoo Finance

Mineralys Stock Rises as FDA Accepts NDA for Hypertension Drug  Yahoo Finance

Mineralys Stock Rises as FDA Accepts NDA for Hypertension Drug - Yahoo Finance

Click here to get full coverage on Mineralys Therapeutics Q4 Earnings Call Highlights - Yahoo Finance

Mineralys Therapeutics Q4 Earnings Call Highlights  Yahoo Finance

Mineralys Therapeutics Q4 Earnings Call Highlights - Yahoo Finance

Click here to get full coverage on Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Sahm

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)  Sahm

MLYS

Price Chart

Key Statistics

Technicals

About MLYS

Latest News

Multiple affiliate sales and option exercises at Mineralys Therapeutics (MLYS) - Stock Titan

How FDA NDA Acceptance for Lorundrostat At Mineralys Therapeutics (MLYS) Has Changed Its Investment Story - Yahoo Finance

Trading the Move, Not the Narrative: (MLYS) Edition - Stock Traders Daily

Advanced Charts

Top Gainers

Top Losers